ARCHIVES

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

This article is from The Cancer Letter archive.

Vol. 18 No. 18 | May 1, 1992

Download PDF Visit The Full Archive

Related Articles

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994

FDA’s Jane Henney

February 11, 1994

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005